Industry Updates
Current Issue:
- Oral Infigratinib Therapy in Children with Achondroplasia
- NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
- Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
- NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction
- Routine Spironolactone in Acute Myocardial Infarction
Food and Drug Administration:
- Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole
- Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
- Battery Pack Correction: Smiths Medical Updates Use Instructions for CADD-Solis Li-ion Rechargeable Battery Packs Due to Risk That Pack Damage May Cause a Circuit Short and Prevent Recharge
- Ventilator Correction: Philips Updates Use Instructions for Trilogy Evo, EvoO2, EV300, Evo Universal, Aeris EVO, Garbin Evo, and LifeVent EVO2 due to Risk of Inaccurate Flow Measurements Caused By Certain In-Line Nebulizer Placements
- 2024 Medical Device Recalls